California Public Employees Retirement System’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-69,300
Closed -$1.67M 3052
2021
Q1
$1.67M Hold
69,300
﹤0.01% 2140
2020
Q4
$1.25M Sell
69,300
-1,500
-2% -$22.4K ﹤0.01% 2325
2020
Q3
$818K Buy
70,800
+1,800
+3% +$29.7K ﹤0.01% 2427
2020
Q2
$1.67M Sell
69,000
-6,262
-8% -$104K ﹤0.01% 1898
2020
Q1
$829K Sell
75,262
-2,600
-3% -$48.6K ﹤0.01% 2114
2019
Q4
$2.06M Buy
77,862
+10,700
+16% +$250K ﹤0.01% 2009
2019
Q3
$1.53M Buy
67,162
+35,662
+113% +$1.12M ﹤0.01% 2050
2019
Q2
$966K Sell
31,500
-1,626
-5% -$34.2K ﹤0.01% 2179
2019
Q1
$550K Sell
33,126
-14,825
-31% -$281K ﹤0.01% 2524
2018
Q4
$918K Sell
47,951
-3,000
-6% -$112K ﹤0.01% 2258
2018
Q3
$2.66M Buy
50,951
+13,145
+35% +$717K ﹤0.01% 1716
2018
Q2
$1.64M Buy
+37,806
New +$1.62M ﹤0.01% 2028

Other funds holding GTHX

California Public Employees Retirement System's GTHX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2021, closing a stake of 69,300 shares — an estimated $1.67M sold.

California Public Employees Retirement System first reported a position in GTHX in Q2 2018 and held it in 12 quarters. The position peaked at $2.66M in Q3 2018. 114 funds tracked by Wall St. Rank hold GTHX as of Q2 2021.

  • California Public Employees Retirement System reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 69,300 G1 Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $1.67M.
  • California Public Employees Retirement System first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
  • California Public Employees Retirement System's G1 Therapeutics, Inc. Common Stock position peaked at $2.66M in Q3 2018.
  • 114 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.